missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
Dolutegravir, MedChemExpress
Description
Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir (S/GSK1349572) inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir retains a high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC50=3.6-5.8 nM).
Specifications
Specifications
| Kemiskt namn eller material | Dolutegravir |
| Fysisk form | Solid |
| CAS | 1051375-16-6 |
| Färg | White |
| Kvantitet | 200 mg |
| Anteckningar om renhetsgrad | Research |
| Molekylformel | C20H19F2N3O5 |
| För användning med (applikation) | COVID-19-anti-virus |
| Synonym | S/GSK1349572 |
| Löslighetsinformation | DMSO : 10 mg/mL (23.84 mM; Need ultrasonic and warming) |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?